Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anisodamine hydrobromide injection for acute circulatory failure in severe infection
ChiCTR-IPR-17012035Phase 4Recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of raceanisodamine in Infection and Cardiovascular collapse (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoints: serum creatinine, PaO2/FiO2 and 13 more. Started Sep 2017; status: recruiting.
02
Drugs
raceanisodamine
03
Conditions
InfectionCardiovascular collapse
Beyond the preview
Go deeper on ChiCTR-IPR-17012035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012035.